Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$721K Hold
5,611
0.21% 60
2026
Q1
$675K Hold
5,611
0.21% 55
2025
Q4
$591K Hold
5,611
0.18% 59
2025
Q3
$471K Hold
5,611
0.15% 63
2025
Q2
$444K Hold
5,611
0.15% 64
2025
Q1
$504K Hold
5,611
0.12% 66
2024
Q4
$558K Hold
5,611
0.15% 59
2024
Q3
$637K Buy
5,611
+100
+2% +$11.9K 0.16% 60
2024
Q2
$682K Sell
5,511
-3,281
-37% -$423K 0.19% 58
2024
Q1
$1.16M Sell
8,792
-790
-8% -$97.4K 0.32% 41
2023
Q4
$1.04M Sell
9,582
-200
-2% -$20.8K 0.32% 42
2023
Q3
$1.01M Buy
+9,782
New +$1.05M 0.34% 40

Other funds holding MRK

Shayne & Jacobs LLC's MRK Position: Q2 2026 in Review

Shayne & Jacobs LLC held its Merck (MRK) position steady in Q2 2026 at 5,611 shares worth $721K. The position accounts for 0.21% of the portfolio, ranked #60.

Shayne & Jacobs LLC first reported a position in MRK in Q3 2023 and has held it in 12 quarters since. The position peaked at $1.16M in Q1 2024. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Shayne & Jacobs LLC held 5,611 shares of Merck worth $721K as of Q2 2026.
  • Shayne & Jacobs LLC left its Merck share count unchanged in Q2 2026.
  • Merck made up 0.21% of Shayne & Jacobs LLC's portfolio in Q2 2026, its #60 holding.
  • Shayne & Jacobs LLC first reported a position in Merck in Q3 2023 and has held it in 12 quarters since.
  • Shayne & Jacobs LLC's Merck position peaked at $1.16M in Q1 2024.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Shayne & Jacobs LLC's 13F filing for Q2 2026, filed 7 Jul 2026.